您的位置: 首页 > 农业专利 > 详情页

COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THEREOF
专利权人:
Teva Pharmaceuticals Australia Pty Ltd
发明人:
POGUE, Sarah L.,WILSON, David S.,DOYLE, Anthony Gerard,BEHRENS, Collette Jane
申请号:
EP15799475
公开号:
EP3137505A4
申请日:
2015.05.01
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
Methods for cancer treatment include administering to a cancer patient an anti-CD38 antibody-attenuated human IFN alpha-2b construct and lenalidomide or pomalidomide. Tumors that may be treated according to these methods include tumors which comprise CD-38 expressing tumor cells, including B-cell lymphoma, multiple myeloma, non-Hodgkins lymphoma, chronic myelogenous leukemia, chronic lymphocytic leukemia, and acute lymphocytic leukemia.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充